A clinical trial to study the effect of the drug lekhaniya mahakashaya on patients of obesity(hyperlipidemia)

upshyatmak study of lekhaniya mahakashya on sthaulya (hyperlipidemia)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011874

Enrollment

Registered

2018-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient of sthaulya (Hyperlipidemia)

Interventions

Intervention1: lekhaniya mahakashaya: DOSE- 48 gm, kwath form twice daily,2 hr. before meal Control Intervention1: Pathya ahar vihar and yoga asan: Pathya ahar vihar and yoga asan for 40 days

Eligibility

Inclusion criteria

Inclusion criteria: The well diagnostic pt.of sthaulya (Hyperlipidemia)will be selected s.cholesterol- >200mg/dl s. triglyceride- > 150mg/dl s.LDL- >110 S.VLDL- > 40mg/dl

Exclusion criteria

Exclusion criteria: pt. suffering with any systemic disease like cardiac and renal disease hypertention. pt suffering for endocrine disorder like diabetes thyroid dysfunction etc. pregnant females and lactating females

Design outcomes

Primary

Measure	Time frame
1.Reduce symptoms of obesity and relief of symtoms like atinidra,chala sphik,utsaha hani,kshudra shawas anga daurgandhya etcTimepoint: 18 month	—

Secondary

Measure	Time frame
1.aetiopathogenesis of sthaulya will be assessed by adopting suitable subjective parameters. 2.Decrease elevated level of s.cholesterol s.triglyceride s. LDL S.VLDL Etc.Timepoint: 18 month	—

Countries

India

Contacts

Public ContactDrsurjeet kumar

Ch Brahm prakash aurved charak sansthan khera dabar najafgarh 73

shreemahalaxmi1969@gmail.com9990174348

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026